NCT06777654

Brief Summary

The goal of this clinical trial is to compare the effects of three groups: (1) unilateral robotic therapy with computerized visual feedback plus unilateral innovative mirror therapy, (2) bilateral robotic therapy with computerized visual feedback plus bilateral innovative mirror therapy, and (3) dose-matched conventional rehabilitation as the control. The investigators will also study the factors predictive of treatment success, identify key predictors of clinical improvement, and distinguish patient profiles most likely to benefit from each regimen. The findings of this clinical trial are expected to advance knowledge about the synergistic effects of unilateral and bilateral hybrid programs. The predictive study of treatment outcomes will inform patient selection in precision rehabilitation toward personalized stroke management.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
28mo left

Started Mar 2025

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Mar 2025Jul 2028

First Submitted

Initial submission to the registry

January 10, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 16, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 31, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

March 27, 2025

Status Verified

January 1, 2025

Enrollment Period

3.3 years

First QC Date

January 10, 2025

Last Update Submit

March 25, 2025

Conditions

Keywords

Robotic RehabilitationMirror TherapyStroke RehabilitationComputerized RehabilitationRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE)

    Baseline, 6 weeks, and 18 weeks

Secondary Outcomes (7)

  • Grip and pinch strength

    Baseline, 6 weeks, and 18 weeks

  • Box and Block Test (BBT)

    Baseline, 6 weeks, and 18 weeks

  • Revised Nottingham Sensory Assessment (rNSA)

    Baseline, 6 weeks, and 18 weeks

  • Motor Activity Log (MAL)

    Baseline, 6 weeks, and 18 weeks

  • ABILHAND Questionnaire

    Baseline, 6 weeks, and 18 weeks

  • +2 more secondary outcomes

Study Arms (3)

Unilateral RT plus unilateral innovative MT

EXPERIMENTAL

Unilateral robotic therapy (RT) with computerized visual feedback plus unilateral innovative mirror therapy (MT)

Other: Robotic therapy (RT)Other: Mirror therapy (MT)

Bilateral RT plus bilateral innovative MT

EXPERIMENTAL

Bilateral robotic therapy (RT) with computerized visual feedback plus bilateral innovative mirror therapy (MT)

Other: Robotic therapy (RT)Other: Mirror therapy (MT)

Dose-matched conventional rehabilitation

ACTIVE COMPARATOR

Dose-matched conventional rehabilitation as the control

Other: Dose-matched control intervention

Interventions

The Bi-Manu-Track (BMT) robot will be provided as the robotic practice. The BMT can be switched from the bilateral practice modules involving bilateral upper limbs to the unilateral module involving the affected upper limb. According to the group assignment, participants will practice the unilateral or bilateral module of BMT training.

Bilateral RT plus bilateral innovative MTUnilateral RT plus unilateral innovative MT

The innovative mirror therapy (MT) program will be conducted with computerized mirror visual feedback and the conventional mirror box therapy. The unilateral MT group will practice on the unilateral module, while the bilateral MT group will practice based on the bilateral module. In the unilateral module, the affected hand will be static on the knee. In contrast, during bilateral MT, participants will be asked to do the same movements using the unaffected and affected arms as symmetrically as possible.

Bilateral RT plus bilateral innovative MTUnilateral RT plus unilateral innovative MT

Participants in the control group will receive therapist-mediated rehabilitation per session.

Dose-matched conventional rehabilitation

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) a first ever-stroke≧3 months and less than 2 years, (2) age range between 30 to 80 years, (3) baseline Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE) between 18 to 56, (4) no excessive muscle spasticity of the affected extremities (Modified Ashworth Scale \< 3 at any joints), (5) able to follow examiners' commands and study instructions (Montreal Cognitive Assessment score≧22), and (6) no fracture of upper extremities within the past 3 months, and (7) no participation in any other experimental rehabilitation or drug studies during study period of this project.

You may not qualify if:

  • (1) acute inflammation and pain, (2) receiving botulinum toxin injections within the past 3 months, and (3) concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation in this research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Wan Fang Hospital, Taipei Medical University

Taipei, Taiwan, Taiwan

Location

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

Location

MeSH Terms

Conditions

Stroke

Interventions

Mirror Movement Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesRehabilitationTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2025

First Posted

January 16, 2025

Study Start

March 31, 2025

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

July 31, 2028

Last Updated

March 27, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations